Suboptimal B-cell depletion is associated with progression independent of relapse activity in multiple sclerosis patients treated with ocrelizumab

Revie L, Jürjens A, Eveslage M, Trümpelmann S, Teschner V, Schulte-Mecklenbeck A, Gross CC, Lünemann JD, Grosch J, Korsukewitz C, Wiendl H, Klotz L.